Drug comparisons
Linagliptin vs Saxagliptin
Compare linagliptin (Tradjenta) vs saxagliptin (Onglyza) DPP-4 inhibitors for type 2 diabetes: renal dosing, heart failure risk, efficacy and side effects.
No comparison dimensions are available for this page.
Clinical context
Triggered when choosing a DPP-4 inhibitor for type 2 diabetes patients with CKD or cardiovascular risk.
Bottom line
Linagliptin is often preferred in renal impairment; saxagliptin requires caution in heart-failure patients; both offer similar A1C lowering.
All medication comparisons